Greer Raymond B reported grant involving 17,888 shares of Lifevantage Corp at $5.87 for $105k on Nov 5, 2026

Grant
Form 4 code A. Grant, award, or other acquisition under Rule 16b-3(d).
Director
DIR
Filed Nov 9, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
$105,002.56Shares × reported price
Shares traded
17,888Common Stock
Price per share
$5.87Reported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
130,707Direct
Trade date
Nov 5, 2026Grant
Filed
Nov 9, 2026, 5:00 PM ET4-day reporting delay
Accession
0001193125-26-453797Code A · Transaction 396179
How reported position traded is calculated

Calculated only for code-P purchases and code-S sales.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

No other transaction rows in this filing.

1 transaction row in this filing. Joint filers share the same rows.

LFVN price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
LFVN · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.

Return windows are pending. The first 7-day window is eligible on Nov 16, 2026. Values appear when the daily price refresh supplies a valid close for that window. Weekends, market holidays and missing prices can delay updates.

Pre-filing1mo ago +16%1w ago +12%1d ago +14%
Returns since7d30d90d180d1y

Footnotes in full

F1: These shares were granted to the reporting person pursuant to the issuer's outside director compensation program and will vest in a single installment on November 5, 2027, subject to the reporting person's continuous service to the issuer through such date. F2: The price reported in Column 4 is equal to the weighted average closing price of the issuer's common stock for the ten trading days ending the day before the date of the grant.